Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus magnesium sulfate as anesthetic adjuncts in transsphenoidal pituitary surgery
IRCT20220528055003N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine and magnesium sulfate in pituitary diseases (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Pain. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
pituitary diseases
Beyond the preview
Go deeper on IRCT20220528055003N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220528055003N1.